Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
European IPOs expected next month -
Company said the financing will help it take advantage of opportunities in the development of metabolic drugs
-
◆ Novo Nordisk brings €6bn trade days after CEO leaves ◆ Tranches priced with similar premiums ◆ No sign of investor fatigue for jumbo corporate trades
-
DocMorris announces Sfr200m rights issue expected in May
-
Stock drops 17% in highly volatile market
-
Deal follows steep share price fall
